The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune Haemolytic Anemia Before and After Tratment

Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic Anemia

NCT06743854 ·Status: NOT_YET_RECRUITING

National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia

NCT07019038 ·Status: RECRUITING

Investigation of Ferritin in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis

NCT02854943 ·Status: COMPLETED

Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients

NCT06708728 ·Status: NOT_YET_RECRUITING

Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor

NCT03656172 ·Status: COMPLETED

The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias

NCT01409967 ·Status: COMPLETED

Anemia of Inflammation: Investigation on Impaired Iron Regulation in Acutely Ill Patients and Their Clinical Outcome

NCT01589874 ·Status: UNKNOWN

Second-line Treatment of Primary Autoimmune Hemolytic Anemia

NCT05057468 ·Status: RECRUITING ·Phase: PHASE3

The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling Immune Defects Behind Common Haematological Diseases

NCT06857604 ·Status: RECRUITING ·Phase: NA

A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge

NCT04920045 ·Status: TERMINATED ·Phase: NA

Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient

NCT06986837 ·Status: COMPLETED

Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases

NCT04526405 ·Status: COMPLETED

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

NCT04138927 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia

NCT01374919 ·Status: COMPLETED ·Phase: NA

Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter

NCT00481221 ·Status: UNKNOWN

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding

NCT00395993 ·Status: COMPLETED ·Phase: PHASE3

Anemia and Inflammation

NCT03618914 ·Status: COMPLETED

Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.

NCT05440838 ·Status: RECRUITING

Effects of Transfusion of Older Stored Red Cells

NCT01534676 ·Status: TERMINATED ·Phase: NA

Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia

NCT01443312 ·Status: COMPLETED

Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy

NCT01956799 ·Status: COMPLETED

Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load

NCT02831712 ·Status: UNKNOWN ·Phase: NA

Iron Depletion and Replacement in Blood Donors

NCT01752413 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)

NCT01996683 ·Status: UNKNOWN ·Phase: NA

Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency

NCT04139265 ·Status: COMPLETED